Repare Therapeutics
Biotechnology ResearchView the employees at
Repare Therapeutics-
Alexanne Bonneau Fortin, MBA Research Scientist II chez Repare Therapeutics
-
Greater Montreal Metropolitan Area
-
Rising Star
Amanda Rode, PMP Life Science Project/Program Manager-
Boston, Massachusetts, United States
-
Rising Star
Abu Ferdous Director, Drug Product Development & Manufacturing-
United States
-
Rising Star
Danielle Vasconcelos Senior Director - Head of Supply Chain at Repare Therapeutics-
Greater Boston
-
Rising Star
Lindsay Flood Associate Director, Executive Operations-
Suffolk County, Massachusetts, United States
-
Top 10%
Overview
Repare Therapeutics (Nasdaq: RPTX) is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor, as well as CCNE1-SL inhibitor and Polθ inhibitor programs. For more information, please visit www.reparerx.com.
-